ConductScience.org, home

Trial · NCT00696878

Adverse events52

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherProcedural painInjury, poisoning and procedural complicationsCorifollitropin Alfa 150 µg121682163
otherHeadacheNervous system disordersCorifollitropin Alfa 150 µg6268291
otherAbortion spontaneousPregnancy, puerperium and perinatal conditionsCorifollitropin Alfa 150 µg4868251
otherPelvic discomfortReproductive system and breast disordersCorifollitropin Alfa 150 µg3568239
otherPelvic painReproductive system and breast disordersCorifollitropin Alfa 150 µg5168260
seriousAutosomal chromosome anomalyCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16822
seriousCongenital arterial malformationCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousCongenital uterine anomalyCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousCytogenetic abnormalityCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousEctopia cordisCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousEncephaloceleCongenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousTrisomy 15Congenital, familial and genetic disordersCorifollitropin Alfa 150 µg16821
seriousConjunctivitisEye disordersCorifollitropin Alfa 150 µg16821
seriousAbdominal painGastrointestinal disordersCorifollitropin Alfa 150 µg16821
seriousPeritoneal haemorrhageGastrointestinal disordersCorifollitropin Alfa 150 µg16821
seriousCholelithiasisHepatobiliary disordersCorifollitropin Alfa 150 µg16821
seriousAppendicitisInfections and infestationsCorifollitropin Alfa 150 µg16821
seriousPost procedural infectionInfections and infestationsCorifollitropin Alfa 150 µg16821
seriousPyelonephritisInfections and infestationsCorifollitropin Alfa 150 µg16821
seriousRespiratory tract infection viralInfections and infestationsCorifollitropin Alfa 150 µg16821

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00696878/events